Investment
Features
FeesSafety
Academy
More
Pluang+

Bausch + Lomb director buys 4,300 shares, doubles stake with matching stock units.

Market News
24 Mar 2026
Seena Hassouna
View Source
Bullish
pluang ai news

Alfonso Eduardo, a director at Bausch + Lomb, purchased 4,300 shares at $17.90 each, spending about $77,000. The company matched this purchase with 4,300 restricted stock units, increasing his total direct holdings to 13,855 shares. This move helps him progress toward a mandatory $400,000 equity ownership requirement within five years. The matching units vest over three years, aligning his interests with shareholders and signaling confidence in the company's long-term prospects in the eye health sector.

More News

Global automotive microcontrollers market to reach $34.31B by 2035, driven by ADAS, electrification, and software-defined vehicles.

Global automotive microcontrollers market to reach $34.31B by 2035, driven by ADAS, electrification, and software-defined vehicles.

The global automotive microcontrollers market is projected to grow from USD 15.49 billion in 2025 to USD 34.31 billion by 2035, at a CAGR of 8.28%. Growth is fueled by increasing adoption of advanced driver-assistance systems (ADAS), vehicle electrif...

Market News
Bullish
3 hours ago
UniFirst named to Selling Power's 60 Best Companies to Sell For list for 23rd year straight.

UniFirst named to Selling Power's 60 Best Companies to Sell For list for 23rd year straight.

UniFirst Corporation has been recognized on Selling Power's 60 Best Companies to Sell For list for the 23rd consecutive year, highlighting its strong sales culture and support for sales professionals. The list evaluates companies on compensation, tra...

Market News
Bullish
4 hours ago
Polymarket odds for Tesla-SpaceX merger drop despite analyst confidence in deal.

Polymarket odds for Tesla-SpaceX merger drop despite analyst confidence in deal.

Traders on Polymarket have significantly reduced their bets on a Tesla-SpaceX merger announcement this year, with the chance of a deal by September 30 now at 11%, down 28 points, and by December 31 at 24%, down 19 points. This decline contrasts with ...

Market News
Neutral
4 hours ago
Eli Lilly to buy psychedelic drugmaker AtaiBeckley for $2.8B to boost mental health drug pipeline

Eli Lilly to buy psychedelic drugmaker AtaiBeckley for $2.8B to boost mental health drug pipeline

Eli Lilly announced it will acquire psychedelic drugmaker AtaiBeckley for $2.8 billion upfront, gaining access to experimental drugs targeting mental health conditions like treatment-resistant depression. AtaiBeckley's lead drug, a DMT-based nasal sp...

Company Fundamentals
Bullish
4 hours ago
Brazil Potash faces procedural court filing but maintains strong legal position on Autazes project.

Brazil Potash faces procedural court filing but maintains strong legal position on Autazes project.

Brazil Potash Corp. disclosed a procedural filing by the Brazilian Federal Public Defender’s Office seeking to suspend activities at its Autazes potash project. The filing challenges prior favorable court decisions but does not introduce new facts or...

Market News
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App